West Pharmaceutical Services Inc.

West Pharmaceutical Services is a manufacturer in the design and production of containment and delivery systems for injectable drugs and healthcare products. The company's products include a variety of primary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing and analytical lab services. The company's segments include: Proprietary Products, which provides proprietary packaging, containment and drug delivery products, and analytical lab services; and Contract-Manufactured Products, which is focused on the design, manufacture, and automated assembly of devices, for pharmaceutical, diagnostic, and medical device customers.
  • TickerWST
  • ISINUS9553061055
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

Kevin Huang

West Pharmaceutical Services, Inc.

WEST PHARM.SVS.INCO. sees a downgrade to Slightly Negative on account of less fundamental stars

The independent financial analyst theScreener just lowered the general evaluation of WEST PHARM.SVS.INCO. (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title now shows 1 out of 4 stars while market behaviour can be considered moderately risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Slightly Negative. As of the analysis date October 8, 2019, the closing price was USD 137.90 and its target price was estimated at USD 121.15.

Kevin Huang

West Pharmaceutical Services, Inc.

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

Kevin Huang

West Pharmaceutical Services, Inc.

Kevin Huang

West Pharmaceutical Services, Inc.

Kevin Huang

West Pharmaceutical Services, Inc.

Kevin Huang

West Pharmaceutical Services, Inc.

Kevin Huang

West Pharmaceutical Services, Inc.

A director sold 21,000 shares at 99.010USD and

A director at West Pharmaceutical Services Inc sold 21,000 shares at 99.010USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules...

Insider bought: Three Directors bought 1,570,840 shares at 0.050CAD.

Three Directors at Westridge Resources Inc bought 1,570,840 shares at 0.050CAD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. ...

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

WEST PHARM.SVS.INCO. sees a downgrade to Slightly Negative on account of less fundamental stars

The independent financial analyst theScreener just lowered the general evaluation of WEST PHARM.SVS.INCO. (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title now shows 1 out of 4 stars while market behaviour can be considered moderately risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Slightly Negative. As of the analysis date October 8, 2019, the closing price was USD 137.90 and its target price was estimated at USD 121.15.

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

GlobalData Department

West Pharmaceutical Services Inc (WST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary West Pharmaceutical Services Inc (West Pharmaceutical) manufactures components and delivery systems for injectable drugs and healthcare products. The company’s major products include primary packaging, containment solutions, cartridge systems and components, prefillable systems, reconstitution and transfer systems, drug delivery systems and specialty components, among others. It also offers contract manufacturing and analytical lab services. West Pharmaceutical serves biologic, generic, pharmaceutical, diagnostic, and medical device companies across the world. The company distributes ...

MarketLine Department

Catalent Inc - Strategy, SWOT and Corporate Finance Report

Catalent Inc - Strategy, SWOT and Corporate Finance Report Summary Catalent Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Catalent, Inc. (Catalent or ‘the company’) is a provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. The company classifies its business into three reportable segments:...

GlobalData Department

West Pharmaceutical Services Inc (WST) - Medical Equipment - Deals and Alliances Profile

Summary West Pharmaceutical Services Inc (West Pharmaceutical) manufactures components and delivery systems for injectable drugs and healthcare products. The company’s major products include primary packaging, containment solutions, cartridge systems and components, prefillable systems, reconstitution and transfer systems, drug delivery systems and specialty components, among others. It also offers contract manufacturing and analytical lab services. West Pharmaceutical serves biologic, generic, pharmaceutical, diagnostic, and medical device companies across the world. The company distributes ...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of Restaurant names are staging price and RS reversals or continue to have bullish formations. (ex. CHUY, JACK, CMG) • There are a few healthcare related names that continue to be bright spots and reflect leadership. (ex. CUTR, TFX, BSX, SYK, ADUS, CHE, COO, WST, TRHC, HUM, AMGN, PBH, MRK, and ZTS.) • REITs continue to show leadership characteristics' as many are hitting price and RS highs. (ex. OHI, SBRA, ESS, IRT, and MAA)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A few Consumer Discretionary names continue to act well. The list is thinning of attractive names though. (ex. FOXF, UEIC, DECK, CHDN, WING, YUM, BOOT, RCI, POOL, DLTR, and AAN) • A number of Health Care Sector names are attractive. (ex. MASI, TFX, CNMD, STE, CRVL, LNTH, HAE, COO, WST, RGEN, ANIK, NEO, and TECH) • Attractive Technology and Services names include: MANH, CDNS, ANSS, AGYS, TTEC, CLGX, MMS, and KBR

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch